0001437749-21-008295.txt : 20210405
0001437749-21-008295.hdr.sgml : 20210405
20210405190854
ACCESSION NUMBER: 0001437749-21-008295
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210331
FILED AS OF DATE: 20210405
DATE AS OF CHANGE: 20210405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEDOUX MARK A
CENTRAL INDEX KEY: 0001115556
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15701
FILM NUMBER: 21807407
MAIL ADDRESS:
STREET 1: 1185 LINDA VISTA DR
CITY: SAN MARCOS
STATE: CA
ZIP: 92069
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NATURAL ALTERNATIVES INTERNATIONAL INC
CENTRAL INDEX KEY: 0000787253
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 841007839
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 1535 FARADAY AVENUE
CITY: CARLSBAD
STATE: CA
ZIP: 92008-7319
BUSINESS PHONE: 6197447340
MAIL ADDRESS:
STREET 1: 1535 FARADAY AVENUE
CITY: CARLSBAD
STATE: CA
ZIP: 92008-7319
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICAN ACQUISITIONS INC
DATE OF NAME CHANGE: 19860929
4
1
rdgdoc.xml
FORM 4
X0306
4
2021-03-31
0000787253
NATURAL ALTERNATIVES INTERNATIONAL INC
NAII
0001115556
LEDOUX MARK A
1535 FARADAY AVENUE
CARLSBAD
CA
92008
1
1
1
CEO/Chairman
Common Stock
2021-03-31
4
S
0
898
15.50
D
39193
D
Common Stock
2021-03-31
4
S
0
1000
15.50
D
524000
I
By LeDoux Family Limited Partnership
Common Stock
2021-04-01
4
S
0
1602
15.50
D
37591
D
Common Stock
2021-04-01
4
S
0
1500
15.50
D
522500
I
By LeDoux Family Limited Partnership
Common Stock
2021-04-05
4
S
0
2500
16.20
D
35091
D
Common Stock
2021-04-05
4
S
0
2500
16.20
D
520000
I
By LeDoux Family Limited Partnership
Common Stock
176500
I
By Self as Trustee for the LeDoux Family Trust U/D/T December 21, 1992
Common Stock
69416
I
By IRA
Common Stock
7200
I
By Self as Custodian for Marcelle Jeannette LeDoux
Common Stock
800
I
By Self as Custodian for Jean-Marc Emile LeDoux
Common Stock
6000
I
By Self as Custodian for Aimee LeDoux
This transaction represents a sale pursuant to a Programmed Plan of Transactions Under Rule 10b5-1(c) of the Securities Exchange Act included as an Exhibit to Form 8-K filed with the SEC on March 26, 2021.
/s/ By Kenneth E. Wolf Attorney in Fact
2021-04-05